A ligand for the orphan NK activating receptor NKp44 is targeted for downregulation by the Kaposi’s Sarcoma-Associated Herpesvirus protein ORF54/dUTPase
Madrid, Alexis and Ganem, Donald (2012) A ligand for the orphan NK activating receptor NKp44 is targeted for downregulation by the Kaposi’s Sarcoma-Associated Herpesvirus protein ORF54/dUTPase. Journal of Virology, 86 (6). pp. 8693-8704. ISSN 0022-538X
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) establishes long-term latent infection in humans and can cause cancers in endothelial and B cells. A functioning immune system is vital for restricting viral proliferation and preventing KSHV-dependent neoplasms. While natural killer (NK) lymphocytes are known to target virus-infected cells for destruction, their importance in the anti-KSHV immune response is not currently understood. Activating receptors on NK cells recognize ligands on target cells, including the uncharacterized ligand(s) for NKp44, termed NKp44L. Here we demonstrate that several NK ligands are affected when KSHV-infected cells are induced to enter the lytic program. We performed a screen of most of the known KSHV genes and found that the product of the ORF54 gene could downregulate NKp44L. The ORF54-encoded protein is a dUTPase; however, dUTPase activity is neither necessary nor sufficient for the downregulation of NKp44L. In addition, we find that ORF54 can also target proteins of the cytokine receptor family and the mechanism of downregulation involves perturbation of membrane protein trafficking. The ORF54-related proteins of other human herpesviruses do not possess this activity, suggesting that the KSHV homolog has evolved a novel immunoregulatory function and that the NKp44-NKp44L signaling pathway contributes to antiviral immunity.
Item Type: | Article |
---|---|
Related URLs: | |
Additional Information: | Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF |
Related URLs: | |
Date Deposited: | 13 Oct 2015 13:14 |
Last Modified: | 13 Oct 2015 13:14 |
URI: | https://oak.novartis.com/id/eprint/6944 |